NEW DELHI : India is the biggest manufacturer of hydroxychloroquine, the anti-malarial drug that is being touted as 'game-changer' in the fight against COVID-19 and is being aggressively sought by US President Donald Trump.
The country has the capacity to quickly ramp up the output of hydroxychloroquine. Days after it added the drug to the list of more than two dozen APIs that cannot be exported while officials get a handle on how much will be needed for COVID-19 outbreak in the country, India on Tuesday agreed to lift the ban after Trump sought supplies for the US.
India manufactures 70% of the world's supply of hydroxychloroquine, according toC (IPA) secretary-general Sudarshan Jain. The country has a production capacity of 40 tonnes of